发明名称 |
Glucokinase activator compositions for the treatment of diabetes |
摘要 |
The present invention relates to pharmaceutical compositions comprising {2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid (FRI-1) in combination with an anti-diabetic drug selected from the group consisting of metformin, sitagliptin or exenatide. The present invention also relates to the use of the pharmaceutical compositions in restoring insulin sensitivity and treating type II diabetes, including reducing body weight in subjects undergoing type II diabetes treatment. |
申请公布号 |
AU2013262895(A1) |
申请公布日期 |
2014.11.13 |
申请号 |
AU20130262895 |
申请日期 |
2013.05.15 |
申请人 |
TRANSTECH PHARMA, LLC |
发明人 |
VALCARCE LOPEZ, MARIA CARMEN;FONG, TUNG |
分类号 |
A61K31/426;A61K31/4985;A61K38/26;A61K45/06;A61P3/04;A61P3/06;A61P3/10;A61P9/10;A61P9/12 |
主分类号 |
A61K31/426 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|